Translational Approach to KRAS Inhibitors and Mapping the Possible Mechanism of KRASi Resistance
1:30 pm - Wednesday 9th September 2026
- The KRAS inhibitor Landscape: From Discovery to Clinical Hurdles
- Establishment of Sotorasib, Adagrasib and Daraxonrasib resistance PDX models. Leveraging MiniPDX and PDX Models for next generation KRASi screening
- Decoding resistance mechanism through integrated bioinformatics